Wegovy weight loss benefits sustained in longest medical trial to date [wc73F5FnZi_]
Wegovy weight loss benefits sustained in longest medical trial to date [wc73F5FnZi_]
| 1h 28m 28s | Video has closed captioning.
The makers of the popular weight loss drug Wegovy say new data, from one of their longest medical trials to date, shows the drug has sustained benefits. Novo Nordisk says patients taking the drug maintained an average 10 per cent weight loss after four years on the treatment. After years of persistent shortages, the drug finally became available to Canadians as of last week, despite being greenlit since 2021. Global health reporter Katherine Ward has more on the results of the trial. For more info, please go to Subscribe to Global News Channel HERE: Like Global News on Facebook HERE: Follow Global News on X HERE: Follow Global News on Instagram HERE: #GlobalNews #wegovy #wegovyweightloss #keto trim pill #kelly clarkson pfizer gummies #ingredients in alli diet pill #healthy keto gummies reviews
Aired: January 05, 2025
Buy Now:
Problems Playing Video? | Closed Captioning